Aridis Pharmaceuticals Price on December 13, 2024

ARDSDelisted Stock  USD 0.27  0.02  8.00%   
If you're considering investing in Aridis Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Aridis Pharmaceuticals stands at 0.27, as last reported on the 14th of December 2024, with the highest price reaching 0.30 and the lowest price hitting 0.20 during the day. We have found twenty-nine technical indicators for Aridis Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Aridis Pharmaceuticals' Downside Deviation of 10.47, mean deviation of 7.73, and Risk Adjusted Performance of 0.0645 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Aridis Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ARDS
Based on monthly moving average Aridis Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aridis Pharmaceuticals by adding Aridis Pharmaceuticals to a well-diversified portfolio.

Related Headline

Eyenovia Headline on 13th of December 2024

Eyenovia, Inc. recently disclosed in an 8-K filing that it has received a notification from Nasdaq regarding the delisting of its common stock due to a significant drop in price. The notification, received on December 12, 2024, stated that as of December 11, 2024, Eyenovias common stock had a closing bid price of 0.10

Aridis Pharmaceuticals Valuation on December 13, 2024

It is possible to determine the worth of Aridis Pharmaceuticals on a given historical date. On December 13, 2024 Aridis was worth 0.25 at the beginning of the trading date compared to the closed value of 0.27. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aridis Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Aridis Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aridis Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aridis Pharmaceuticals' related companies.
 Open High Low Close Volume
12/14/2024
  0.25    0.30    0.20    0.27    0.00  
Backtest Aridis Pharmaceuticals  |  Aridis Pharmaceuticals History  |  Aridis Pharmaceuticals Valuation 
Open Value
0.25
0.27
Closing Value
0.25
Upside

Aridis Pharmaceuticals Trading Date Momentum on December 13, 2024

Aridis Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Aridis Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aridis Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aridis financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Aridis Pharmaceuticals Pink Sheet history

Aridis Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aridis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aridis Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aridis Pharmaceuticals stock prices may prove useful in developing a viable investing in Aridis Pharmaceuticals
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies to treat life-threatening infections. Aridis Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Los Gatos, California. Aridis Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.

Aridis Pharmaceuticals Pink Sheet Technical Analysis

Aridis Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Aridis Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aridis Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Aridis Pharmaceuticals Period Price Range

Low
December 14, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Aridis Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Aridis Pharmaceuticals December 14, 2024 Market Strength

Market strength indicators help investors to evaluate how Aridis Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aridis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Aridis Pharmaceuticals pink sheet market strength indicators, traders can identify Aridis Pharmaceuticals entry and exit signals to maximize returns

Aridis Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Aridis Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Aridis Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aridis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Consideration for investing in Aridis Pink Sheet

If you are still planning to invest in Aridis Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aridis Pharmaceuticals' history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Correlations
Find global opportunities by holding instruments from different markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance